IFITM1, CD10, SMA, and h-caldesmon as a helpful combination in differential diagnosis between endometrial stromal tumor and cellular leiomyoma

IFITM1, CD10, SMA, and h-caldesmon as a helpful combination in differential diagnosis between endometrial stromal tumor and cellular leiomyoma

Abstract Background The differential diagnosis of endometrial stromal tumor (EST) and uterine cellular leiomyoma (CL) remains a challenge in clinical practice, especially low grade endometrial stromal sarcoma (ESS) and CL, suggesting the need for novel immunomarkers panels for differential diagnosis...

Full description

Bibliographic Details
Main Authors: Weilin Zhao, Mei Cui, Ruiqi Zhang, Xihua Shen, Xin Xiong, Xinhua Ji, Lin Tao, Wei Jia, Lijuan Pang, Zhenzhu Sun, Chun Wang, Hong Zou
Format: Article
Language:English
Published: BMC 2021-09-01
Series:BMC Cancer
Subjects:
IFITM1
CD10
SMA
H-caldesmon
Endometrial stromal tumor
Cellular leiomyoma
Online Access:https://doi.org/10.1186/s12885-021-08781-w

Internet

https://doi.org/10.1186/s12885-021-08781-w

Similar Items